Survival analysis indicated that hypermethylation of CLDN22 and CLDN19 was associated with poorer prognosis in LGG (Figure 1e), while CLDN14 and CLDN11 exhibited higher mutation frequencies in both GBM and LGG (Figure 1f). The gene discussed is CLDN11; the disease is glioblastoma.